Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for kids with severe skin condition in major drug trial

NCT ID NCT03997786

Ongoing Disease control Sponsor: Sun Pharmaceutical Industries Limited Source: ClinicalTrials.gov ↗

Summary

This study is testing a medication called tildrakizumab to see if it can effectively and safely control moderate-to-severe plaque psoriasis in children and teenagers aged 6 to 18. It will compare the drug against a placebo (an inactive substance) and another approved treatment. The main goals are to see how well it clears skin symptoms and improves quality of life for young patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site 1

    Fountain Valley, California, 92708, United States

  • Site 14

    Spokane, Washington, 99202, United States

  • Site 2

    Thousand Oaks, California, 91320, United States

  • Site 20

    Miami, Florida, 33126, United States

  • Site 39

    Wroclaw, 51-503, Poland

  • Site 41

    Barcelona, 08041, Spain

  • Site 47

    Las Palmas de Gran Canaria, 35019, Spain

  • Site 50

    Ostrowiec Świętokrzyski, 27-400, Poland

  • Site 51

    Katowice, 40-611, Poland

  • Site 52

    Szczecin, 70-332, Poland

  • Site 53

    Warsaw, 02-507, Poland

  • Site 54

    Lodz, 90-265, Poland

  • Site 56

    Lodz, 90-436, Poland

  • Site 57

    Bialystok, 15-453, Poland

  • Site 58

    Lublin, 20-573, Poland

  • Site 59

    Sosnowiec, 41-200, Poland

  • Site 61

    Debrecen, H-4032, Hungary

  • Site 62

    Budapest, H-1036, Hungary

  • Site 63

    Budapest, H-1033, Hungary

  • Site 64

    Kaposvár, H-7400, Hungary

  • Site 7

    Miami, Florida, 33173, United States

  • Site 71

    Lucknow, 226005, India

  • Site 74

    Surat, 395002, India

  • Site 79

    Ahmedabad, 380009, India

  • Site 90

    Trnava, 91775, Slovakia

  • Site 91

    Svidník, 8901, Slovakia

  • Site 92

    Bardejov, 8501, Slovakia

Conditions

Explore the condition pages connected to this study.

MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS